These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 15006826)

  • 1. Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia.
    Rosón B; Carratalà J; Fernández-Sabé N; Tubau F; Manresa F; Gudiol F
    Arch Intern Med; 2004 Mar; 164(5):502-8. PubMed ID: 15006826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early and late treatment failure in community-acquired pneumonia.
    Garcia-Vidal C; Carratalà J
    Semin Respir Crit Care Med; 2009 Apr; 30(2):154-60. PubMed ID: 19296415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors and outcome of community-acquired pneumonia due to Gram-negative bacilli.
    Falguera M; Carratalà J; Ruiz-Gonzalez A; Garcia-Vidal C; Gazquez I; Dorca J; Gudiol F; Porcel JM
    Respirology; 2009 Jan; 14(1):105-11. PubMed ID: 18699803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causes and risk factors for rehospitalization of patients hospitalized with community-acquired pneumonia.
    Jasti H; Mortensen EM; Obrosky DS; Kapoor WN; Fine MJ
    Clin Infect Dis; 2008 Feb; 46(4):550-6. PubMed ID: 18194099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome.
    Menéndez R; Torres A; Zalacaín R; Aspa J; Martín Villasclaras JJ; Borderías L; Benítez Moya JM; Ruiz-Manzano J; Rodríguez de Castro F; Blanquer J; Pérez D; Puzo C; Sánchez Gascón F; Gallardo J; Alvarez C; Molinos L;
    Thorax; 2004 Nov; 59(11):960-5. PubMed ID: 15516472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes.
    Carratalà J; Mykietiuk A; Fernández-Sabé N; Suárez C; Dorca J; Verdaguer R; Manresa F; Gudiol F
    Arch Intern Med; 2007 Jul; 167(13):1393-9. PubMed ID: 17620533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence-based emergency medicine/critically appraised topic. Evidence behind the 4-hour rule for initiation of antibiotic therapy in community-acquired pneumonia.
    Yu KT; Wyer PC
    Ann Emerg Med; 2008 May; 51(5):651-62, 662.e1-2. PubMed ID: 18272253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Medical outcomes and antimicrobial compliance according to the Chilean Society of Respiratory Diseases guidelines for hospitalized patients with community acquired pneumonia].
    Díaz A; Kuzmanic G; Platzer L; Sanfuentes F; Espinoza MA; Saldías F
    Rev Med Chil; 2003 Aug; 131(8):847-56. PubMed ID: 14558238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia.
    Chalmers JD; Singanayagam A; Murray MP; Scally C; Fawzi A; Hill AT
    Thorax; 2009 Jul; 64(7):592-7. PubMed ID: 19131449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia.
    Frei CR; Restrepo MI; Mortensen EM; Burgess DS
    Am J Med; 2006 Oct; 119(10):865-71. PubMed ID: 17000218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pneumonias in patients with malignant hemopathies. Their etiology, response to treatment and prognostic factors in 69 patients (88 episodes)].
    Fernández Avilés F; Batlle M; Ribera JM; Matas L; Rosell A; Manzano JL; Flores A; Millá F; Feliu E
    Med Clin (Barc); 1999 Mar; 112(9):321-5. PubMed ID: 10220762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aetiology of, and risk factors for, recurrent community-acquired pneumonia.
    Garcia-Vidal C; Carratalà J; Fernández-Sabé N; Dorca J; Verdaguer R; Manresa F; Gudiol F
    Clin Microbiol Infect; 2009 Nov; 15(11):1033-8. PubMed ID: 19673961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community-acquired pneumonia in very elderly patients: causative organisms, clinical characteristics, and outcomes.
    Fernández-Sabé N; Carratalà J; Rosón B; Dorca J; Verdaguer R; Manresa F; Gudiol F
    Medicine (Baltimore); 2003 May; 82(3):159-69. PubMed ID: 12792302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute myocardial infarction in hospitalized patients with community-acquired pneumonia.
    Ramirez J; Aliberti S; Mirsaeidi M; Peyrani P; Filardo G; Amir A; Moffett B; Gordon J; Blasi F; Bordon J
    Clin Infect Dis; 2008 Jul; 47(2):182-7. PubMed ID: 18533841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early evolution of arterial oxygenation in severe community-acquired pneumonia: a prospective observational study.
    Wu CL; Lin FJ; Lee SY; Lee CH; Peng MJ; Chen PJ; Kuo HT
    J Crit Care; 2007 Jun; 22(2):129-36. PubMed ID: 17548024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The epidemiology and clinical features of Legionella pneumonia (LP) in patients older than 60 years old who were hospitalized with pneumonia in northern Israel].
    Ben-Dror G; Mizerizky Y; Viar G; Zuker M; Miron D
    Harefuah; 2002 Aug; 141(8):680-2, 763. PubMed ID: 12222127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes for hospitalized patients with Legionella pneumonia in the antigenuria era: the influence of levofloxacin therapy.
    Mykietiuk A; Carratalà J; Fernández-Sabé N; Dorca J; Verdaguer R; Manresa F; Gudiol F
    Clin Infect Dis; 2005 Mar; 40(6):794-9. PubMed ID: 15736010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia.
    Houck PM; Bratzler DW; Nsa W; Ma A; Bartlett JG
    Arch Intern Med; 2004 Mar; 164(6):637-44. PubMed ID: 15037492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
    Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
    Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe community-acquired pneumonia: an Australian perspective.
    Wilson PA; Ferguson J
    Intern Med J; 2005 Dec; 35(12):699-705. PubMed ID: 16313544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.